Can a temporary isolated fetal megacystis during first trimester result in unexplained intrauterine fetal death at third trimester?: a case report and review of the literature

2012 ◽  
Vol 20 (2) ◽  
pp. 68-71
Author(s):  
Servet Hacıvelioğlu
Keyword(s):  
Case Report ◽  
Fetal Death ◽  
First Trimester ◽  
Intrauterine Fetal Death ◽  
Review Of The Literature ◽  
Third Trimester

scholarly journals Intrauterine fetal death in triplet gestation caused by feto-fetal transfusion syndrome – a case report

2016 ◽  
Vol 2 (4) ◽  
pp. 213-217
Author(s):  
Lingling Long ◽  
Jie Yan ◽  
Qiyan Li ◽  
Ziqi Zhou ◽  
Haixiao Deng ◽  
...  
Keyword(s):  
Case Report ◽  
Fetal Death ◽  
Intrauterine Fetal Death

scholarly journals Expectant Management Leading to Successful Vaginal Delivery following Intrauterine Fetal Death in a Woman with an Incarcerated Uterus

2017 ◽  
Vol 2017 ◽  
pp. 1-4 ◽  
Author(s):  
Masafumi Yamamoto ◽  
Mio Takami ◽  
Ryosuke Shindo ◽  
Michi Kasai ◽  
Shigeru Aoki
Keyword(s):  
Vaginal Delivery ◽  
Fetal Death ◽  
Expectant Management ◽  
Intrauterine Fetal Death ◽  
Third Trimester ◽  
Spontaneous Reduction

Expectant management leads to successful vaginal delivery following intrauterine fetal death in a woman with an incarcerated uterus. Management of intrauterine fetal death in the second or third trimester of pregnancy in women with an incarcerated uterus is challenging. We report a case of successful vaginal delivery following intrauterine fetal death by expectant management in a woman with an incarcerated uterus. In cases of intrauterine fetal death in women with an incarcerated uterus, vaginal delivery may be possible if the incarceration is successfully reduced. If the reduction is impossible, expectant management can reduce uterine retroversion, thereby leading to spontaneous reduction of the incarcerated uterus. Thereafter, vaginal delivery may be possible.

scholarly journals Low Dose Vaginal Misoprostol in the Management of Women with Intrauterine Fetal Death

2010 ◽  
Vol 3 ◽  
pp. CMWH.S5797
Author(s):  
M.N. El-Gharib ◽  
M.T. El-Ebyary ◽  
T.S. Alhawary ◽  
S.H. Elshourbagy
Keyword(s):  
Fetal Death ◽  
Mean Value ◽  
University Hospital ◽  
Intrauterine Fetal Death ◽  
Third Trimester ◽  
Trimester Pregnancy ◽  
Observational Cohort ◽  
The Mean ◽  
Vaginal Misoprostol ◽  
Duration Of Gestation

Objectives The study was conducted to assess the effectiveness and side effects of vaginal misoprostol (Vagiprost® tablet) in termination of second and third trimester pregnancy complicated with intrauterine fetal death. Design A prospective observational cohort study. Setting Tanta University Hospital. Patients The study was carried out on 324 women with fetal demise in the second and third trimesters. Cases were collected during the period from January 2008 to December 2009. Intervention All patients were subjected to history taking, physical examination, Bishop Scoring. Application of 25 μg misoprostol in the posterior fornix of the vagina, this will be repeated every 4 hours over 24 hours. The adverse effects, progress, and outcomes were assessed. Results the success rate was 90% and 45% in women with third and second trimesters respectively. The mean induction-termination interval was 8.95 ± 2.63 and 15.3 ± 5.37 hours for women with third and second trimesters respectively. The induction termination interval correlated negatively with the duration of gestation. Approximately, 90% of second trimester and 55% of third trimester women required oxytocin augmentation. The mean value of total required dose of misoprostol was 166.3 ± 7.5 and 120 ± 28.79 μg for women with second and third trimesters respectively. Conclusion Vagiprost appears to be a safe, effective, practical, and inexpensive method for termination of third trimester pregnancy complicated with of intrauterine fetal death (IUFD), its effects increase with parity and duration of gestation.

scholarly journals Heterotopic pregnancy: case report of a successful first trimester metacyesis management and a viable third trimester outcome

2018 ◽  
Vol 8 (1) ◽  
pp. 332
Author(s):  
Arvind Kumar Singh ◽  
Shazia Khan
Keyword(s):  
Case Report ◽  
Maternal Morbidity ◽  
Assisted Reproductive Technologies ◽  
First Trimester ◽  
Reproductive Technologies ◽  
Heterotopic Pregnancy ◽  
Third Trimester ◽  
Intrauterine Pregnancy ◽  
The Past ◽  
Maternal Morbidity And Mortality

Heterotopic pregnancies are rare combined intra and extrauterine pregnancies, the incidence of which has shown an increase over the past decade with the rising trend in assisted reproductive technologies (0.75-1.5%). Authors report a case of a 29 year old primigravida, a post IVF conception who presented at 6 weeks POG with a ruptured tubal and a viable intrauterine pregnancy. She underwent an emergency laparoscopic right salpingectomy and continued with her intrauterine pregnancy successfully till term. The article emphasizes the need of scanning the adnexa carefully in early pregnancy to diagnose and manage heterotopic pregnancy as early as possible to prevent catastrophic haemorrhage and maternal morbidity and mortality later.

Successful Use of Argatroban During the Third Trimester of Pregnancy: Case Report and Review of the Literature

2008 ◽  
Vol 28 (12) ◽  
pp. 1531-1536 ◽  
Author(s):  
Sallie K Young ◽  
Hamid A Al-Mondhiry ◽  
Sonia J Vaida ◽  
Anthony Ambrose ◽  
John J Botti
Keyword(s):  
Case Report ◽  
Review Of The Literature ◽  
Third Trimester ◽  
The Third

Co-Occurrence of Massive Perivillous Fibrin Deposition and Chronic Intervillositis: Case Report

2006 ◽  
Vol 9 (3) ◽  
pp. 234-238 ◽  
Author(s):  
Martin A. Weber ◽  
Peter G.J. Nikkels ◽  
Karen Hamoen ◽  
Johannes J. Duvekot ◽  
Ronald r. de Krijger
Keyword(s):  
Case Report ◽  
High Risk ◽  
Fetal Death ◽  
Fetal Outcome ◽  
Intrauterine Fetal Death ◽  
Histological Findings ◽  
Fibrin Deposition ◽  
Intervillous Space ◽  
Intrauterine Fetal Growth Restriction ◽  
First Time

Chronic intervillositis (CI) and massive perivillous fibrin deposition (MFD), together with its related entity, maternal floor infarction (MFI), are rare and poorly understood placental lesions. Both MFD/MFI and CI are associated with poor fetal outcome and high risk of recurrence. We report a patient who was found to have both MFD and CI in the same placenta, resulting in severe intrauterine fetal growth restriction and intrauterine fetal death at 37 weeks of gestation. Characteristic histological findings included both very extensive perivillous deposition of fibrinoid material and a heavy infiltrate of CD68-positive macrophages/monocytes in the maternal intervillous space. To our knowledge, this is the first time the co-occurrence of MFD and CI is reported in the literature.

Sign in / Sign up

Export Citation Format

Share Document